Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Document Type
Year range
1.
SciFinder; 2020.
Preprint | SciFinder | ID: ppcovidwho-4098

ABSTRACT

A review. Since Sept., 2019, COVID-19 spreads all over 26 countries, and more than 70 000 people got infected till Feb. 22th, 2020. COVID-19 has strong infectivity and can result in acute respiratory distress syndrome and multiple organ failure. These severe complications are believed to be the consequence of cytokine storm caused by the virus infection. In the "diagnosis and treatment of novel coronavirus pneumonia", glucocorticoid is recommended as the immunosuppressive agents to prevent acute immune reaction. But the usage of glucocorticoid may bring risks such as superinfection, prolonged course of disease or severe residual effects. Traditional Chinese Medicine might have advantages in the moderation of immune system. Actually, Traditional Chinese Medicine is now applied in the treatment of COVID-19 clin., and exhibits excellent therapeutic effects. In this review, the potential usage of Traditional Chinese drugs or Traditional prescriptions in inhibiting cytokine storm and acute lung injury are analyzed, which would be an effective strategy for the treatment of COVID-19.

SELECTION OF CITATIONS
SEARCH DETAIL